Mpox (monkeypox)

Mpox (monkeypox) is a thematic concept centered on prevention, detection, and treatment of orthopoxvirus infections. Core tracks span vaccines and antivirals, PCR/rapid diagnostics, epidemiological surveillance and digital tracing, infection-control/PPE, and public-health logistics.The sector's total market cap is 363.73 billion USD, with a 24h change of +0.63%. Among 5 constituents, 1 are up (20.00%) and 4 are down (80.00%). The top gainer is Abbott Laboratories (ABT), with a 24h increase of +2.30%.Modest rebound with weak breadth and narrow leadership. Near term, follow liquid leaders; longer term, prioritize clinical/regulatory milestones, balance-sheet strength, and rate sensitivity.
Name
Last Price
Change %
Last Price / Change %
Chart
Price Range
Action
ABT
ABTAbbott Laboratories
103.10$103.00
+2.30%
-0.09%
PM
103.10
+2.30%
$102.32$103.89
GILD
GILDGilead Sciences Inc
129.33$129.90
-1.13%
+0.44%
PM
129.33
-1.13%
$129.33$130.45
DGX
DGXQuest Diagnostics Inc.
227.86--
-0.01%
--
PM
227.86
-0.01%
$227.86$232.35
CODX
CODXCo-Diagnostics, Inc.
2.10$2.17
-4.10%
+3.33%
PM
2.10
-4.10%
$2.08$2.20
GOVX
GOVXGeoVax Labs, Inc. New
0.73$0.76
-13.59%
+3.78%
PM
0.73
-13.59%
$0.70$0.93